Russell Investments Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$245M Sell
1,109,315
-46,680
-4% -$12.9M 0.21% 66
2026
Q1
$342M Sell
1,155,995
-38,450
-3% -$11.4M 0.37% 34
2025
Q4
$326M Buy
1,194,445
+151,857
+15% +$41.3M 0.36% 37
2025
Q3
$282M Buy
1,042,588
+108,954
+12% +$29.6M 0.32% 47
2025
Q2
$257M Buy
933,634
+83,620
+10% +$22.7M 0.33% 47
2025
Q1
$225M Sell
850,014
-49,925
-6% -$12.3M 0.31% 54
2024
Q4
$209M Buy
899,939
+80,755
+10% +$18.6M 0.29% 56
2024
Q3
$181M Sell
819,184
-13,492
-2% -$2.79M 0.26% 64
2024
Q2
$164M Sell
832,676
-86,218
-9% -$17.8M 0.26% 67
2024
Q1
$198M Sell
918,894
-60,346
-6% -$12.7M 0.31% 50
2023
Q4
$206M Buy
979,240
+22,035
+2% +$4.7M 0.37% 38
2023
Q3
$192M Buy
957,205
+26,932
+3% +$5.35M 0.38% 37
2023
Q2
$172M Sell
930,273
-52,141
-5% -$9.64M 0.33% 46
2023
Q1
$188M Buy
982,414
+95,829
+11% +$17.3M 0.37% 40
2022
Q4
$149M Buy
886,585
+167,135
+23% +$29M 0.31% 52
2022
Q3
$128M Buy
719,450
+73,726
+11% +$14.6M 0.28% 61
2022
Q2
$132M Buy
645,724
+38,383
+6% +$8.14M 0.27% 66
2022
Q1
$145M Sell
607,341
-39,876
-6% -$9.37M 0.25% 70
2021
Q4
$148M Sell
647,217
-856
-0.1% -$188K 0.24% 72
2021
Q3
$126M Sell
648,073
-7,318
-1% -$1.48M 0.21% 93
2021
Q2
$139M Buy
655,391
+43,630
+7% +$9.21M 0.23% 72
2021
Q1
$125M Buy
611,761
+131,085
+27% +$25.8M 0.22% 85
2020
Q4
$86.5M Sell
480,676
-75,340
-14% -$12.8M 0.17% 121
2020
Q3
$92.7M Sell
556,016
-332,161
-37% -$55.9M 0.2% 102
2020
Q2
$144M Sell
888,177
-148,843
-14% -$26.7M 0.32% 46
2020
Q1
$180M Buy
1,037,020
+161,774
+18% +$32.2M 0.47% 29
2019
Q4
$175M Buy
875,246
+53,649
+7% +$11M 0.33% 44
2019
Q3
$175M Sell
821,597
-56,801
-6% -$11.9M 0.34% 41
2019
Q2
$170M Sell
878,398
-275,279
-24% -$50.7M 0.32% 47
2019
Q1
$189M Buy
1,153,677
+105,349
+10% +$18.6M 0.35% 41
2018
Q4
$196M Buy
1,048,328
+117,089
+13% +$21.6M 0.44% 31
2018
Q3
$159M Buy
931,239
+22,634
+2% +$3.81M 0.3% 54
2018
Q2
$149M Sell
908,605
-269,940
-23% -$44.1M 0.31% 50
2018
Q1
$190M Sell
1,178,545
-83,421
-7% -$13.3M 0.32% 50
2017
Q4
$185M Buy
1,261,966
+146,605
+13% +$20.9M 0.31% 52
2017
Q3
$151M Buy
1,115,361
+110,227
+11% +$13.9M 0.26% 68
2017
Q2
$126M Buy
1,005,134
+389,908
+63% +$46.6M 0.22% 85
2017
Q1
$73.1M Buy
615,226
+214,893
+54% +$25.8M 0.13% 170
2016
Q4
$46.3M Buy
+400,333
New +$44.5M 0.09% 262

Other funds holding CME

Russell Investments Group's CME Position: Q2 2026 in Review

Russell Investments Group reduced its CME Group (CME) stake by 4% in Q2 2026, selling an estimated $12.9M and leaving 1,109,315 shares worth $245M. The position accounts for 0.21% of the portfolio, ranked #66.

Russell Investments Group first reported a position in CME in Q4 2016 and has held it in 39 quarters since. The position peaked at $342M in Q1 2026. 956 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Russell Investments Group held 1,109,315 shares of CME Group worth $245M as of Q2 2026.
  • Russell Investments Group sold 46,680 CME Group shares in Q2 2026, an estimated $12.9M.
  • CME Group made up 0.21% of Russell Investments Group's portfolio in Q2 2026, its #66 holding.
  • Russell Investments Group first reported a position in CME Group in Q4 2016 and has held it in 39 quarters since.
  • Russell Investments Group's CME Group position peaked at $342M in Q1 2026.
  • 956 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.